Citigroup Maintains Neutral on Qiagen, Raises Price Target to $52
Benzinga Newsdesk 5 days ago
Analyst RatingsNewsPrice Target
Citigroup analyst Albert Hu maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $45 to $52.
Citigroup analyst Albert Hu maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $45 to $52.